Global X MSCI 挪威ETF NORW 深 滬
已收盤 11-06 16:00:00 美东时间
35.75
-0.732
-2.01%
華盛通- 最 高35.99
- 今 開35.86
- 成交量 2.05万股
- 最 低 35.66
- 昨 收 36.4818
- 總市值 8959.38万
- 52周最高 38.38
- 市盈率 靜 --
- 換手率 0.82%
- 52周最低 25.3055
- 委 比 -33.33%
- 總股本 250.61万
- 歷史最高 38.38
- 量 比 1.09
- 振 幅 0.90%
- 歷史最低 -2.4271
- 每 手 1
- 風險率 3.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FactSet Declares Dividend
FactSet announced that its Board of Directors approved a regular quarterly cash dividend of $1.16 per share, payable on December 17, 2026, to holders of record as of November 30, 2026. FactSet, a leading global intelligence and AI solutions provider to the financial markets, serves over 9,200 global clients and 260,000 individual users, offering tailored solutions across various sectors.
11-06 13:07
Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November
Corbus Pharmaceuticals Holdings, Inc. announced that its CEO, Yuval Cohen, Ph.D., will present at three conferences in November 2026: the Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026; the Jefferies Global Healthcare Conference on November 18, 2026; and the 9th Annual Evercore Healthcare Conference on December 1, 2026. Each event will include presentations, fireside chats, and one-on-one investor meetings. Investors i...
11-05 13:00
FactSet and Hamilton Lane Announce Strategic Partnership to Deliver Integrated Private Markets Analytics
FactSet and Hamilton Lane announce a strategic partnership to integrate Hamilton Lane's private markets data into FactSet's portfolio analytics platform, enabling unified analysis of public and private portfolios. The collaboration addresses the need for comprehensive tools to evaluate and manage multi-asset class investments, offering proprietary benchmarking, enhanced risk models, and whole portfolio monitoring. This partnership aims to empower...
11-02 14:01
Reed’s Schedules Third Quarter 2026 Conference Call for November 11 at 8:30 a.m. ET
Reed’s, Inc. will host a conference call on November 11, 2026, at 8:30 a.m. Eastern time to discuss its Q3 2026 financial results. Participants can dial in at (800) 717-1738 (US) or (646) 307-1865 (international), using conference ID 03446. The call will also be webcast live and available for replay on the company’s investor relations website. Reed’s is a leading provider of premium, natural ginger beverages, sold in over 32,000 stores nationwide...
10-29 12:00
Reed’s Announces Pricing of $10.0 Million Private Placement
Reed’s, Inc. has entered into a PIPE financing agreement with its majority investor, D&D Source of Life Holding Ltd., to sell 17,421,602 shares of common stock at $0.574 per share, raising approximately $10 million. The funds will be used for working capital and general corporate purposes. The transaction is expected to close on October 30, 2026, subject to customary conditions. Reed’s, a leader in craft ginger beverages, aims to use the proceeds...
10-28 17:30
Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Corbus Pharmaceuticals will present late-breaking data from the CRB-913 Canyon-1 Phase 1B study at Obesity Week 2026 in National Harbor, MD. The presentation, titled "Efficacy, Safety, and Tolerability of CRB-913 in the Ph1b CANYON-1 Study," will be delivered by Harold Bays, M.D., on November 15, 2026, at 2:30 p.m. ET in Exhibit Hall BCD. Corbus is a clinical-stage company developing innovative therapies for oncology and obesity, with CRB-913 bei...
10-22 12:00
Reed’s Provides Response to Unusual Market Action
Reed’s, Inc. has noticed unusual trading activity in its common stock on the NYSE American on October 20-21, 2026. The company issued a press release under Section 401(d) of the NYSE American Company Guide and is unable to determine if corrective actions are needed. There have been no material developments in its business. Reed’s is a leading provider of premium, natural ginger beverages, with products sold in over 32,000 stores nationwide.
10-21 17:00
Kevin O'Leary Explains Why His Big AI Bet is Uranium, Not Big Tech: 'The Trade is Now the Energy Trade'
Venture capitalist and investor Kevin O’Leary says he is shifting his investment strategy away from direct artificial intelligence (AI) technology stocks toward energy infrastructure, identifying electricity production and uranium as his primary focus for the next 36 months. Shift From Tech to Power...
09-23 19:37
Norway wealth fund posts record H1 profit as tech stocks surge
Norway’s sovereign wealth fund posted a record NOK 1.75T profit in the first half of 2026, helped by gains in technology stocks, as its exposure to the global chip boom continued to grow. The NOK 2.3T...
08-12 21:59
